Not Yet RecruitingNot Applicable

Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

30 participantsStarted 2024-09-01

Plain-language summary

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to : * Clinically based on Change in the Size and Color of Hemangioma. * Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology . * Comparison of Complications associated with Bleomycin and Diode Laser.

Who can participate

Age range3 Months – 12 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 3 Months and 1 Year old. * Non Complicated Infantile Hemangioma Exclusion Criteria: * Younger than 3 Months or older than 1 Year. * Complicated Infantile Hemangioma

What they're measuring

Effect of diode laser on hemangioma

Timeframe: 3 years

Trial details

NCT IDNCT06510829

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

View on ClinicalTrials.gov More Bleomycin Adverse Reaction trials